• Return to Headlines

Coherus Bioscien: The Winning Streak Continues (CHRS)

By David Diaz

Shares of Coherus Bioscien (NASDAQ:CHRS) traded today at $21.00, breaking its 52-week high. This new high was reached on below average trading volume as 316,000 shares traded hands, while the average 30-day volume is approximately 827,000 shares.

Coherus Biosciences, Inc. is a biopharmaceutical company. The Company develops biosimilar therapeutics to aid patients.

Coherus Bioscien share prices have moved between a 52-week high of $21.00 and a 52-week low of $8.34 and are now trading 152% above that low price at $21.00 per share. Over the past week, the 200-day moving average (MA) has remained constant while the 50-day MA has advanced 1.8%.

Coherus Bioscien has overhead space with shares priced $21.00, or 30.0% below the average consensus analyst price target of $30.00. The stock should find initial support at its 50-day moving average (MA) of $17.20 and further support at its 200-day MA of $14.19.

SmarTrend recommended that subscribers consider buying shares of Coherus Bioscien on January 9th, 2019 as our proprietary SmarTrend analytics indicated a new Uptrend was in progress when shares hit $11.23. Since that recommendation, shares of Coherus Bioscien have risen 84.1%. We continue to monitor CHRS for any potential shift so investors can protect gains and will alert SmarTrend subscribers immediately.

Keywords: 52 week high/lows coherus bioscien

Ticker(s): CHRS